Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · IEX Real-Time Price · USD
1.770
+0.010 (0.57%)
Jul 22, 2024, 10:04 AM EDT - Market open
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 41 employees as of December 31, 2023. The number of employees increased by 3 or 7.89% compared to the previous year.
Employees
41
Change (1Y)
3
Growth (1Y)
7.89%
Revenue / Employee
n/a
Profits / Employee
-$731,195
Market Cap
11.55M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41 | 3 | 7.89% |
Dec 31, 2022 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Mustang Bio | 80 |
RedHill Biopharma | 53 |
Senti Biosciences | 48 |
Vaccinex | 40 |
Lumos Pharma | 33 |
Imunon | 33 |
Dominari Holdings | 28 |
BioRestorative Therapies | 11 |
CLDI News
- 4 days ago - Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform - GlobeNewsWire
- 6 days ago - Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board - GlobeNewsWire
- 16 days ago - Calidi to Effect Reverse Stock Split - Business Wire
- 25 days ago - Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors - Business Wire
- 5 weeks ago - Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13 - Business Wire
- 6 weeks ago - Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors - Business Wire
- 7 weeks ago - Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting - Business Wire
- 7 weeks ago - Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds - Business Wire